Although having a higher percentage of West African genetic ancestry was associated with shorter breast cancer DFS in this study, this finding was observed in the HR-positive/ERBB2-negative subgroup but not in the TNBC subgroup, suggesting that West African genetic ancestry may be differentially associated with survival outcomes based on IHC subtype. The gene discussed is ERBB2; the disease is breast carcinoma.